Due to its own technology, INVIBES has attracted international advertisers and works with a network of media groups (Bertelsmann, Hearst, Unify, Groupe Marie Claire, Axel Springer, and more…). Since launching its business in 2012, the company has recorded an average annual growth of close to 100%. Its ambition is to maintain this strong growth thanks to a favorable context in France and to the success of its international overtures (Switzerland, Spain, Brazil and Poland). ATOUT CAPITAL advised PHARMASIMPLE for its fundraising of 500,000€ from business angels and the listing of its securities on Free Market of EURONEXT Paris under the direct listing procedure. 120,000 shares, representing 5.7 % of its share capital, were offered to the market by one of the main shareholders, VP VENTURES. The shares of INVIBES ADVERTISING have been listed since July 25th 2016 (ISIN BE0974299316/Ticker: MLINV). This first step should allow INVIBES to become familiar with stock markets before an expected second fundraising to finance its growth and to pursue its international expansion plan.